Patents by Inventor Omar Robles

Omar Robles has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF
    Publication number: 20260092050
    Abstract: Disclosed herein, inter alia, are compounds and methods of use thereof for the modulation of certain chemokine receptor activity.
    Type: Application
    Filed: January 17, 2025
    Publication date: April 2, 2026
    Inventors: Parcharee Tivitmahaisoon, David J. Wustrow, Mikhail Zibinsky, Omar Robles
  • CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF
    Publication number: 20250122208
    Abstract: Described herein, inter alia, are compounds and methods of use thereof for the modulation of certain chemokine receptor activity.
    Type: Application
    Filed: October 4, 2024
    Publication date: April 17, 2025
    Inventors: Blanca I. Gomez, Michelle Yoo Min Ko, Daniel Poon, Omar Robles, Grant M. Shibuya, Vi-Anh T. Vu, Joel Aponte-Guzman, David J. Wustrow, Mikhail Zibinsky
  • Chemokine receptor modulators and uses thereof
    Patent number: 12240837
    Abstract: Disclosed herein, inter alia, are compounds and methods of use thereof for the modulation of certain chemokine receptor activity.
    Type: Grant
    Filed: April 5, 2023
    Date of Patent: March 4, 2025
    Assignee: RAPT Therapeutics, Inc.
    Inventors: Parcharee Tivitmahaisoon, David J. Wustrow, Mikhail Zibinsky, Omar Robles
  • CRYSTALLINE FORMS OF C-C CHEMOKINE RECEPTOR TYPE 4 ANTAGONIST AND USES THEREOF
    Publication number: 20240317768
    Abstract: Crystalline forms of a C—C chemokine receptor type 4 (CCR4) antagonist, oral dosage forms of same and methods of using and preparing same, are provided.
    Type: Application
    Filed: June 7, 2024
    Publication date: September 26, 2024
    Inventors: David J. Arnold, Omar Robles, Duane E. Rudisill, David J. Wustrow, Mikhail Zibinsky, Sami Karaborni
  • Crystalline forms of C-C chemokine receptor type 4 antagonist and uses thereof
    Patent number: 12006318
    Abstract: Crystalline forms of a C-C chemokine receptor type 4 (CCR4) antagonist, oral dosage forms of same and methods of using and preparing same, are provided.
    Type: Grant
    Filed: November 13, 2020
    Date of Patent: June 11, 2024
    Assignee: RAPT Therapeutics, Inc.
    Inventors: David J. Arnold, Omar Robles, Duane E. Rudisill, David J. Wustrow, Mikhail Zibinsky, Sami Karaborni
  • Pyrazole pyrimidine compounds and uses thereof
    Patent number: 11918582
    Abstract: Disclosed herein are pyrazole pyrimidine compounds that modulate and/or inhibit hematopoietic progenitor kinase 1, as well as methods of making such compounds and therapeutic methods of using same.
    Type: Grant
    Filed: March 14, 2022
    Date of Patent: March 5, 2024
    Assignee: RAPT Therapeutics, Inc.
    Inventors: Cyril Bucher, Adrian Dukes, Blanca Gomez, Hannah Haley, Dennis Hu, Jeffrey J. Jackson, Michelle Yoo Min Ko, Paul Leger, Anqi Ma, Andrew A. Ng, Daniel Poon, Omar Robles, Anton Shakhmin, Grant Shibuya, Parcharee Tivitmahaisoon, Vi-Anh Vu, David J. Wustrow, Mikhail Zibinsky
  • CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF
    Publication number: 20230322741
    Abstract: Disclosed herein, inter alia, are compounds and methods of use thereof for the modulation of certain chemokine receptor activity.
    Type: Application
    Filed: April 5, 2023
    Publication date: October 12, 2023
    Inventors: Parcharee Tivitmahaisoon, David J. Wustrow, Mikhail Zibinsky, Omar Robles
  • PYRAZOLE PYRIMIDINE COMPOUNDS AND USES THEREOF
    Publication number: 20220305018
    Abstract: Disclosed herein are pyrazole pyrimidine compounds that modulate and/or inhibit hematopoietic progenitor kinase 1, as well as methods of making such compounds and therapeutic methods of using same.
    Type: Application
    Filed: March 14, 2022
    Publication date: September 29, 2022
    Inventors: Cyril Bucher, Adrian Dukes, Blanca Gomez, Hannah Haley, Dennis Hu, Jeffrey J. Jackson, Michelle Yoo Min Ko, Paul Leger, Anqi Ma, Andrew A. Ng, Daniel Poon, Omar Robles, Anton Shakhmin, Grant Shibuya, Parcharee Tivitmahaisoon, Vi-Anh Vu, David J. Wustrow, Mikhail Zibinsky
  • Pyrazolo-pyrimidin-amino-cycloalkyl compounds and their therapeutic uses
    Patent number: 11046699
    Abstract: Disclosed herein are pyrozolo-pyrimidin-amino-cycloalkyl compounds, analogs thereof, pharmaceutical compositions comprising thereof and therapeutic uses therefor.
    Type: Grant
    Filed: June 4, 2019
    Date of Patent: June 29, 2021
    Assignee: RAPT THERAPEUTICS, INC.
    Inventors: Minna H. T. Bui, Adrian O. Dukes, Xinping Han, Dennis X. Hu, Jeffrey J. Jackson, Yoo Min Ko, Paul R. Leger, Anqi Ma, Jack Maung, Andrew A. Ng, Akinori Okano, Omar Robles, Grant Shibuya, Hunter P. Shunatona, Jacob B. Schwarz, Anton A. Shakhmin, David J. Wustrow, Mikhail Zibinsky
  • CRYSTALLINE FORMS OF C-C CHEMOKINE RECEPTOR TYPE 4 ANTAGONIST AND USES THEREOF
    Publication number: 20210139487
    Abstract: Crystalline forms of a C-C chemokine receptor type 4 (CCR4) antagonist, oral dosage forms of same and methods of using and preparing same, are provided.
    Type: Application
    Filed: November 13, 2020
    Publication date: May 13, 2021
    Inventors: David J. ARNOLD, Omar ROBLES, Duane E. RUDISILL, David J. WUSTROW, Mikhail ZIBINSKY, Sami KARABORNI
  • Beta-amino pateamine a derivatives and methods for treating chronic lymphocytic leukemia
    Patent number: 10889596
    Abstract: Pateamine A derivatives, pharmaceutical compositions that include the derivatives, and methods for treating chronic lymphocytic leukemia using the derivatives.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: January 12, 2021
    Assignee: The Texas A&M University System
    Inventors: Daniel Romo, Kenneth G. Hull, Mingzhao Zhu, Omar Robles
  • Alpha-amino pateamine A derivatives and methods for treating chronic lymphocytic leukemia
    Patent number: 10870662
    Abstract: Pateamine A derivatives and pharmaceutical compositions that include the derivatives. The pateamine A derivatives are ?-amino pateamine A derivatives that lack the C5-methyl group of pateamine A.
    Type: Grant
    Filed: August 29, 2019
    Date of Patent: December 22, 2020
    Assignee: The Texas A&M University System
    Inventors: Daniel Romo, Ken Hull, Mingzhao Zhu, Omar Robles
  • ALPHA-AMINO PATEAMINE A DERIVATIVES AND METHODS FOR TREATING CHRONIC LYMPHOCYTIC LEUKEMIA
    Publication number: 20190382417
    Abstract: Pateamine A derivatives and pharmaceutical compositions that include the derivatives. The pateamine A derivatives are ?-amino pateamine A derivatives that lack the C5-methyl group of pateamine A.
    Type: Application
    Filed: August 29, 2019
    Publication date: December 19, 2019
    Applicant: The Texas A&M University System
    Inventors: Daniel Romo, Ken Hull, Mingzhao Zhu, Omar Robles
  • PYRAZOLO-PYRIMIDIN-AMINO-CYCLOALKYL COMPOUNDS AND THEIR THERAPEUTIC USES
    Publication number: 20190375753
    Abstract: Disclosed herein are pyrozolo-pyrimidin-amino-cycloalkyl compounds, analogs thereof, pharmaceutical compositions comprising thereof and therapeutic uses therefor.
    Type: Application
    Filed: June 4, 2019
    Publication date: December 12, 2019
    Inventors: Minna H. T. Bui, Adrian O. Dukes, Xinping Han, Dennis X. Hu, Jeffrey J. Jackson, Yoo Min Ko, Paul R. Leger, Anqi Ma, Jack Maung, Andrew A. Ng, Akinori Okano, Omar Robles, Grant Shibuya, Hunter P. Shunatona, Jacob B. Schwarz, Anton A. Shakhmin, David J. Wustrow, Mikhail Zibinsky
  • Alpha-amino pateamine A derivatives and methods for treating chronic lymphocytic leukemia
    Patent number: 10407444
    Abstract: Pateamine A derivatives and pharmaceutical compositions that include the derivatives. The pateamine A derivatives are ?-amino pateamine A derivatives that lack the C5-methyl group of pateamine A.
    Type: Grant
    Filed: March 31, 2016
    Date of Patent: September 10, 2019
    Assignee: The Texas A&M University System
    Inventors: Daniel Romo, Ken Hull, Mingzhao Zhu, Omar Robles
  • BETA-AMINO PATEAMINE A DERIVATIVES AND METHODS FOR TREATING CHRONIC LYMPHOCYTIC LEUKEMIA
    Publication number: 20190177339
    Abstract: Pateamine A derivatives, pharmaceutical compositions that include the derivatives, and methods for treating chronic lymphocytic leukemia using the derivatives.
    Type: Application
    Filed: March 31, 2017
    Publication date: June 13, 2019
    Applicant: The Texas A&M University System
    Inventors: Daniel Romo, Kenneth G. Hull, Mingzhao Zhu, Omar Robles
  • ALPHA-AMINO PATEAMINE A DERIVATIVES AND METHODS FOR TREATING CHRONIC LYMPHOCYTIC LEUKEMIA
    Publication number: 20180118764
    Abstract: Pateamine A derivatives and pharmaceutical compositions that include the derivatives. The pateamine A derivatives are ?-amino pateamine A derivatives that lack the C5-methyl group of pateamine A.
    Type: Application
    Filed: March 31, 2016
    Publication date: May 3, 2018
    Applicant: The Texas A&M University System
    Inventors: Daniel Romo, Ken Hull, Mingzhao Zhu, Omar Robles